{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:50:37Z","timestamp":1787309437008,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Natural Science Foundation","doi-asserted-by":"crossref","award":["No. ZR2022MH297"],"award-info":[{"award-number":["No. ZR2022MH297"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yantai Science and Technology Plan","award":["No. 2021MSGY043"],"award-info":[{"award-number":["No. 2021MSGY043"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-024-01577-z","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T23:30:02Z","timestamp":1732145402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical significance of Cyclin D1 by complete quantification detection in mantle cell lymphoma: positive indicator in prognosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Yan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"1577_CR1","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102(3):83\u201387."},{"key":"1577_CR2","doi-asserted-by":"crossref","unstructured":"Alba N, S\u00edlvia Be\u00e0, Pedro J, Campo E. Molecular pathogenesis of mantle cell lymphoma[J]. Hematol Oncol Clin North Am. 2020;34(5):795\u2013807.","DOI":"10.1016\/j.hoc.2020.05.002"},{"issue":"2","key":"1577_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00277-003-0774-2","volume":"83","author":"G Lenz","year":"2004","unstructured":"Lenz G, Dreyling M, Hiddemann W. Mantle cell lymphoma: established therapeutic options and future directions[J]. Ann Hematol. 2004;83(2):71\u20137.","journal-title":"Ann Hematol"},{"key":"1577_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1477-7819-12-55","volume":"12","author":"W Baoming Ren","year":"2014","unstructured":"Baoming Ren W, Li Y, Yang, et al. The impact of Cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis[J]. World J Surg Oncol. 2014;12:55.","journal-title":"World J Surg Oncol"},{"key":"1577_CR5","unstructured":"Lin Y, Cheng A, Solanki M, Su W, Zaki M, Tirado CA. Amplification of Cyclin D1 in Urothelial Carcinoma[J]. J Assoc Genet Technol. 2022;48(1):4\u20139."},{"issue":"1","key":"1577_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/modpathol.2013.125","volume":"27","author":"S Roland","year":"2014","unstructured":"Roland S, George NT, Diana R, et al. Cyclin D1\/ Cyclin D1status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response[J]. Mod Pathol. 2014;27(1):87\u201395.","journal-title":"Mod Pathol"},{"issue":"1","key":"1577_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3892\/etm.2016.3969","volume":"13","author":"H Zhongxiao Lin","year":"2017","unstructured":"Zhongxiao Lin H, Sheng C, You, et al. Inhibition of the Cyclin D1 promoter in response to sonic hedgehog signaling pathway transduction is mediated by Gli1[J]. Exp Ther Med. 2017;13(1):307\u201314.","journal-title":"Exp Ther Med"},{"issue":"1","key":"1577_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2019.04.005","volume":"381","author":"J Xi","year":"2019","unstructured":"Xi J, Sun Y, Zhang M, et al. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT\/GSK3\u03b2\/Cyclin D1 pathway[J]. Exp Cell Res. 2019;381(1):1\u20139.","journal-title":"Exp Cell Res"},{"key":"1577_CR9","doi-asserted-by":"crossref","unstructured":"Ahlin C, Lundgren C, Embrets\u00e9n-Varro E, Jirstr\u00f6m K, Blomqvist C, Fj\u00e4llskog M -L. High expression of Cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers[J]. Breast cancer Res Treat. 2017;164(3):667\u201378.","DOI":"10.1007\/s10549-017-4294-5"},{"key":"1577_CR10","doi-asserted-by":"crossref","unstructured":"FrancescaIda M, Francesca DA. Cyclin D1 in Cancer: a molecular connection for cell cycle control, Adhesion and Invasion in Tumor and Stroma[J]. Cells. 2020;9(12):2648.","DOI":"10.3390\/cells9122648"},{"key":"1577_CR11","doi-asserted-by":"crossref","unstructured":"Pandey A, Bahl C, Sharma S, Singh N, Behera D. Functional role of Cyclin D1polymorphism (G870A) in modifying susceptibility and overall survival of north Indian lung cancer patients[J]. Tumori. 2018;104(3):179\u201387.","DOI":"10.1177\/0300891617753477"},{"issue":"2","key":"1577_CR12","first-page":"741","volume":"16","author":"K Sajjad","year":"2016","unstructured":"Sajjad K, Jaudah AA, Hasan MA, et al. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia[J]. BMC Cancer. 2016;16(2):741.","journal-title":"BMC Cancer"},{"key":"1577_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1515\/med-2019-0108","volume":"14","author":"Q Quan Liang","year":"2019","unstructured":"Quan Liang Q, GuoYing Y. Cyclin D1 is a new target gene of tumor suppressor miR-520e in breast cancer[J]. Open Med(Wars. 2019;14:913\u20139.","journal-title":"Open Med(Wars"},{"key":"1577_CR14","doi-asserted-by":"crossref","unstructured":"Ortiz BA, Garcia D, Vicente Y, Palka M, Bellas C, Martin P. Prognostic significance of Cyclin D1 protein expression and gene amplification in invasive breast carcinoma[J]. PloS One. 2017;12(11):e0188068.","DOI":"10.1371\/journal.pone.0188068"},{"issue":"4","key":"1577_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/01635581.2018.1559933","volume":"71","author":"Y Swarnalatha","year":"2019","unstructured":"Swarnalatha Y, Vidhya VG, Murugan A. Isochamanetin is a selective inhibitor for Cyclin D1 in SKOV3 cell Lines[J]. Nutr Cancer. 2019;71(4):657\u201367.","journal-title":"Nutr Cancer"},{"issue":"4","key":"1577_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1309\/42CQ0HU7XEY9QMQX","volume":"129","author":"M Ehinger","year":"2008","unstructured":"Ehinger M, Linderoth J, Christensson B, et al. A subset of CD5-diffuse large B-cell lymphomas expresses nuclear Cyclin D1 with aberrations at the Cyclin D1 locus[J]. Am J Clin Pathol. 2008;129(4):630\u20138.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"1577_CR17","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0002-9440(10)65710-0","volume":"153","author":"NS Aguilera","year":"1998","unstructured":"Aguilera NS, Bijwaard KE, Duncan B, et al. Differential expression of Cyclin D1 in mantle cell lymphoma and other non-hodgkin\u2019s lymphomas[J]. Am J Pathol. 1998;153(6):1969\u201376.","journal-title":"Am J Pathol"},{"key":"1577_CR18","doi-asserted-by":"crossref","unstructured":"Tian G, Tang F, Yang C, Zhang W, Bergquist J, Wang B, et al. Quantitative dot blot analysis (QDB), aversatile high throughput immunoblot method. [J] Oncotarget. 2017;8:58553\u201362.","DOI":"10.18632\/oncotarget.17236"},{"issue":"1","key":"1577_CR19","doi-asserted-by":"publisher","first-page":"12502","DOI":"10.1038\/s41598-020-69471-4","volume":"10","author":"G Yu","year":"2020","unstructured":"Yu G, Zhang W, Zhang Y, et al. Developing a routine lab test for absolute quantification of HER2 in FFPE breast cancer tissues using quantitative dot blot (QDB) method[J]. Sci Rep. 2020;10(1):12502.","journal-title":"Sci Rep"},{"key":"1577_CR20","doi-asserted-by":"crossref","unstructured":"Hao J, Lyu Y, Zou J, Zhang Y, Xie S, Jing L, et al. Improving prognosis of surrogate assay for breast Cancer patients by Absolute quantitation of Ki67 protein levels using quantitative dot blot (QDB) Method[J]. Front Oncol. 2021,11:737781.","DOI":"10.3389\/fonc.2021.737781"},{"key":"1577_CR21","doi-asserted-by":"crossref","unstructured":"Yuandong Zhu, Xu X, Zheng X, Zheng Z. Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma[J]. J Investig Meg. 2019;67(2):331\u20137.","DOI":"10.1136\/jim-2018-000837"},{"key":"1577_CR22","doi-asserted-by":"crossref","unstructured":"Wu M, Li Y, Huang H, Xu W, Wang Y, Huang H, et al. Initial treatment patterns and survival outcomes of mantle cell lymphoma patients managed at Chinese academic centers in the rituximab era: a real-world Study[J]. Front Oncol. 2022;11:770988.","DOI":"10.3389\/fonc.2021.770988"},{"key":"1577_CR23","doi-asserted-by":"crossref","unstructured":"Allen MG. Diagnostic immunohistochemistry: what can go wrong and how to prevent it. Arch Pathol Lab Med. 2016;140(9):893\u20138.","DOI":"10.5858\/arpa.2016-0119-RA"},{"key":"1577_CR24","doi-asserted-by":"crossref","unstructured":"Hao J, Zhang W, Lyu Y, Zou J, Zhang Y, Lyu J, et al. Combined use of Cyclin D1 and Ki67 for prognosis of Luminal-Like breast Cancer Patients[J]. Front Oncol. 2021;11:737794.","DOI":"10.3389\/fonc.2021.737794"},{"key":"1577_CR25","doi-asserted-by":"publisher","first-page":"103038","DOI":"10.1016\/j.critrevonc.2020.103038","volume":"153","author":"C Sergio","year":"2020","unstructured":"Sergio C, Maurilio P, Andr\u00e9s JM, Ferreri. Mantle cell lymphoma[J]. Crit Rev Oncol Hematol. 2020;153:103038.","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01577-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01577-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01577-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:04:10Z","timestamp":1732147450000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01577-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01577-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4258808\/v1","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"12 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}